| Year |
Citation |
Score |
| 2021 |
Reinhardt BC, Habib O, Shaw KL, Garabedian EK, Carbonaro-Sarracino DA, Terrazas DR, Campo-Fernandez B, De Oliveira S, Moore TB, Ikeda A, Engel BC, Podsakoff GM, Hollis RP, Fernandes A, Jackson CR, ... ... Cornetta K, et al. Long-term Outcomes after Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency (ADA SCID). Blood. PMID 33974038 DOI: 10.1182/blood.2020010260 |
0.327 |
|
| 2020 |
Scott M, Clarke D, Lipsitz Y, Brandwein H, Allickson J, Alzebdeh D, Aleksic S, Kraft C, Lhu L, Cornetta K. Transitioning from development to commercial: risk-based guidance for critical materials management in cell therapies. Cytotherapy. PMID 32713719 DOI: 10.1016/J.Jcyt.2020.06.011 |
0.304 |
|
| 2020 |
Cornetta KG, Rubin L, Long R, Duffy L. The National Gene Vector Biorepository. Eleven Years of Providing Resources to the Gene Therapy Community. Human Gene Therapy. PMID 31910049 DOI: 10.1089/Hum.2019.317 |
0.373 |
|
| 2020 |
Cornetta K, Koop S, Nance E, House K, Duffy L. Replication-Competent Lentivirus Analysis of Vector-Transduced T Cell Products Used in Cancer Immunotherapy Clinical Trials. Methods in Molecular Biology (Clifton, N.J.). 2086: 181-194. PMID 31707676 DOI: 10.1007/978-1-0716-0146-4_13 |
0.378 |
|
| 2019 |
Cornetta K. Gene Transfer to HSCs: Finding the Leukemia in Murine Leukemia Viruses. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31109833 DOI: 10.1016/J.Ymthe.2019.05.003 |
0.375 |
|
| 2019 |
Kohn DB, Shaw KL, Garabedian E, Carbonaro-Sarracino DA, Moore TB, Oliveira SND, Tse J, Shupien S, Terrazas D, Davila A, Icreverzi A, Yu A, Chun KM, Casas CE, Barman P, ... ... Cornetta K, et al. Lentiviral Gene Therapy with Autologous Hematopoietic Stem and Progenitor Cells (HSPCs) for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency (ADA-SCID): Results in an Expanded Cohort Blood. 134: 3345-3345. DOI: 10.1182/Blood-2019-123432 |
0.376 |
|
| 2018 |
Cornetta K, Patel K, Wanjiku CM, Busakhala N. Equitable Access to Gene Therapy: A Call to Action for the American Society of Gene and Cell Therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 30454956 DOI: 10.1016/J.Ymthe.2018.11.002 |
0.365 |
|
| 2018 |
Puig-Saus C, Parisi G, Garcia-Diaz A, Krystofinski PE, Sandoval S, Zhang R, Champhekar AS, McCabe J, Cheung-Lau GC, Truong NA, Vega-Crespo A, Komenan MDS, Pang J, Macabali MH, Saco JD, ... ... Cornetta K, et al. IND-enabling studies for a clinical trial to genetically program a persistent cancer-targeted immune system. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30409823 DOI: 10.1158/1078-0432.Ccr-18-0963 |
0.364 |
|
| 2018 |
Cornetta K, Duffy L, Feldman SA, Mackall CL, Davila ML, Curran KJ, Junghans RP, Tang JY, Kochenderfer JN, O'Cearbhaill R, Archer G, Kiem HP, Shah NN, Delbrook C, Kaplan R, et al. Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience. Molecular Therapy. Methods & Clinical Development. 10: 371-378. PMID 30211249 DOI: 10.1016/J.Omtm.2018.08.006 |
0.423 |
|
| 2017 |
Flotte TR, Daniels E, Benson J, Bevett-Rose JM, Cornetta K, Diggins M, Johnston J, Sepelak S, Van Der Loo J, Wilson JM, McDonald CL. The Gene Therapy Resource Program: A Decade of Dedication to Translational Research by the National Heart, Lung, and Blood Institute. Human Gene Therapy. Clinical Development. PMID 29130351 DOI: 10.1089/Humc.2017.170 |
0.328 |
|
| 2017 |
Cornetta K, Duffy L, Turtle CJ, Jensen M, Forman S, Binder-Scholl G, Fry T, Chew A, Maloney DG, June CH. Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28970045 DOI: 10.1016/J.Ymthe.2017.09.008 |
0.417 |
|
| 2017 |
Shaw KL, Garabedian E, Mishra S, Barman P, Davila A, Carbonaro D, Shupien S, Silvin C, Geiger S, Nowicki B, Smogorzewska EM, Brown B, Wang X, de Oliveira S, Choi Y, ... ... Cornetta K, et al. Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency. The Journal of Clinical Investigation. PMID 28346229 DOI: 10.1172/Jci90367 |
0.397 |
|
| 2016 |
Shaw AM, Joseph GL, Jasti AC, Sastry-Dent L, Witting S, Cornetta K. Differences in vector genome processing and illegitimate integration of non-integrating lentiviral vectors. Gene Therapy. PMID 27682478 DOI: 10.1038/Gt.2016.69 |
0.586 |
|
| 2016 |
Punwani D, Kawahara M, Yu J, Sanford U, Roy S, Patel K, Carbonaro DA, Karlen AD, Khan S, Cornetta KG, Rothe M, Schambach A, Kohn DB, Malech HL, McIvor RS, et al. Lentivirus Mediated Correction of Artemis-deficient Severe Combined Immunodeficiency. Human Gene Therapy. PMID 27611239 DOI: 10.1089/Hum.2016.064 |
0.435 |
|
| 2015 |
Eissenberg LG, Rettig MP, Ritchey JK, Prior JL, Schwarz SW, Frye J, White BS, Fulton RS, Ghobadi A, Cooper ML, Couriel DR, Seegulam ME, Piwnica-Worms D, Dehdashti F, Cornetta K, et al. [(18)F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and Feasibility. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 1110-22. PMID 25807290 DOI: 10.1038/Mt.2015.48 |
0.374 |
|
| 2015 |
Gaspar HB, Buckland K, Carbonaro DA, Shaw K, Barman P, Davila A, Gilmour KC, Booth C, Terrazs D, Cornetta K, Paruzynski A, Schmidt M, Sokolic R, Candotti F, Thrasher AJ, et al. C-8. Immunological and Metabolic Correction After Lentiviral Vector Gene Therapy for ADA Deficiency Molecular Therapy. 23. DOI: 10.1016/S1525-0016(16)33866-7 |
0.457 |
|
| 2014 |
Gao H, Hawkins T, Jasti A, Chen YH, Mockaitis K, Dinauer M, Cornetta K. Development and Evaluation of Quality Metrics for Bioinformatics Analysis of Viral Insertion Site Data Generated Using High Throughput Sequencing. Biomedicines. 2: 195-210. PMID 28548067 DOI: 10.3390/Biomedicines2020195 |
0.308 |
|
| 2014 |
Shaw A, Cornetta K. Design and Potential of Non-Integrating Lentiviral Vectors. Biomedicines. 2: 14-35. PMID 28548058 DOI: 10.3390/Biomedicines2010014 |
0.453 |
|
| 2014 |
Wolstein O, Boyd M, Millington M, Impey H, Boyer J, Howe A, Delebecque F, Cornetta K, Rothe M, Baum C, Nicolson T, Koldej R, Zhang J, Keech N, Camba Colón J, et al. Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor. Molecular Therapy. Methods & Clinical Development. 1: 11. PMID 26015947 DOI: 10.1038/Mtm.2013.11 |
0.376 |
|
| 2014 |
Chodon T, Comin-Anduix B, Chmielowski B, Koya RC, Wu Z, Auerbach M, Ng C, Avramis E, Seja E, Villanueva A, McCannel TA, Ishiyama A, Czernin J, Radu CG, Wang X, ... ... Cornetta K, et al. Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2457-65. PMID 24634374 DOI: 10.1158/1078-0432.Ccr-13-3017 |
0.375 |
|
| 2014 |
Carbonaro DA, Zhang L, Jin X, Montiel-Equihua C, Geiger S, Carmo M, Cooper A, Fairbanks L, Kaufman ML, Sebire NJ, Hollis RP, Blundell MP, Senadheera S, Fu PY, Sahaghian A, ... ... Cornetta K, et al. Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 607-22. PMID 24256635 DOI: 10.1038/Mt.2013.265 |
0.46 |
|
| 2013 |
Cornetta K. Biomedicines-Moving Biologic Agents into Approved Treatment Options. Biomedicines. 1: 1-2. PMID 28548053 DOI: 10.3390/Biomedicines1010001 |
0.323 |
|
| 2013 |
Du LM, Nurden P, Nurden AT, Nichols TC, Bellinger DA, Jensen ES, Haberichter SL, Merricks E, Raymer RA, Fang J, Koukouritaki SB, Jacobi PM, Hawkins TB, Cornetta K, Shi Q, et al. Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A. Nature Communications. 4: 2773. PMID 24253479 DOI: 10.1038/Ncomms3773 |
0.315 |
|
| 2013 |
McDonald CL, Benson J, Cornetta K, Diggins M, Johnston JC, Sepelak S, Wang G, Wilson JM, Wright JF, Skarlatos SI. Advancing translational research through the NHLBI Gene Therapy Resource Program (GTRP). Human Gene Therapy. Clinical Development. 24: 5-10. PMID 23692378 DOI: 10.1089/Humc.2013.036 |
0.32 |
|
| 2013 |
O'Reilly M, Kohn DB, Bartlett J, Benson J, Brooks PJ, Byrne BJ, Camozzi C, Cornetta K, Crystal RG, Fong Y, Gargiulo L, Gopal-Srivastava R, High KA, Jacobson SG, Jambou RC, et al. Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012. Human Gene Therapy. 24: 355-62. PMID 23517518 DOI: 10.1089/Hum.2013.064 |
0.33 |
|
| 2013 |
Tremblay JP, Xiao X, Aartsma-Rus A, Barbas C, Blau HM, Bogdanove AJ, Boycott K, Braun S, Breakefield XO, Bueren JA, Buschmann M, Byrne BJ, Calos M, Cathomen T, Chamberlain J, ... ... Cornetta K, et al. Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 266-8. PMID 23369965 DOI: 10.1038/Mt.2013.4 |
0.373 |
|
| 2013 |
Farag SS, Srivastava S, Messina-Graham S, Schwartz J, Robertson MJ, Abonour R, Cornetta K, Wood L, Secrest A, Strother RM, Jones DR, Broxmeyer HE. In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies. Stem Cells and Development. 22: 1007-15. PMID 23270493 DOI: 10.1089/Scd.2012.0636 |
0.331 |
|
| 2013 |
Cornetta K, Tessanne K, Long C, Yao J, Satterfield C, Westhusin M. Transgenic sheep generated by lentiviral vectors: safety and integration analysis of surrogates and their offspring. Transgenic Research. 22: 737-45. PMID 23180364 DOI: 10.1007/S11248-012-9674-3 |
0.349 |
|
| 2013 |
Aloia AL, Duffy L, Pak V, Lee KE, Sanchez-Martinez S, Derse D, Heidecker G, Cornetta K, Rein A. A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay Gene Therapy. 20: 169-176. PMID 22402321 DOI: 10.1038/Gt.2012.18 |
0.353 |
|
| 2012 |
Yang S, Karne NK, Goff SL, Black MA, Xu H, Bischof D, Cornetta K, Rosenberg SA, Morgan RA, Feldman SA. A simple and effective method to generate lentiviral vectors for ex vivo gene delivery to mature human peripheral blood lymphocytes. Human Gene Therapy Methods. 23: 73-83. PMID 22515320 DOI: 10.1089/Hgtb.2011.199 |
0.462 |
|
| 2012 |
Shaw A, Bischof D, Jasti A, Ernstberger A, Hawkins T, Cornetta K. Using Pulmozyme DNase treatment in lentiviral vector production. Human Gene Therapy Methods. 23: 65-71. PMID 22428981 DOI: 10.1089/Hgtb.2011.204 |
0.373 |
|
| 2012 |
Leath A, Cornetta K. Developing novel lentiviral vectors into clinical products. Methods in Enzymology. 507: 89-108. PMID 22365770 DOI: 10.1016/B978-0-12-386509-0.00005-3 |
0.382 |
|
| 2012 |
Bear AS, Morgan RA, Cornetta K, June CH, Binder-Scholl G, Dudley ME, Feldman SA, Rosenberg SA, Shurtleff SA, Rooney CM, Heslop HE, Dotti G. Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements? Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 246-9. PMID 22297819 DOI: 10.1038/Mt.2011.288 |
0.392 |
|
| 2012 |
Witting SR, Li LH, Jasti A, Allen C, Cornetta K, Brady J, Shivakumar R, Peshwa MV. Efficient large volume lentiviral vector production using flow electroporation. Human Gene Therapy. 23: 243-9. PMID 21933028 DOI: 10.1089/Hum.2011.088 |
0.382 |
|
| 2011 |
Fang J, Jensen ES, Boudreaux MK, Du LM, Hawkins TB, Koukouritaki SB, Cornetta K, Wilcox DA. Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs. Proceedings of the National Academy of Sciences of the United States of America. 108: 9583-8. PMID 21606353 DOI: 10.1073/Pnas.1016394108 |
0.33 |
|
| 2011 |
Broxmeyer HE, Lee MR, Hangoc G, Cooper S, Prasain N, Kim YJ, Mallett C, Ye Z, Witting S, Cornetta K, Cheng L, Yoder MC. Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood. 117: 4773-7. PMID 21393480 DOI: 10.1182/Blood-2011-01-330514 |
0.368 |
|
| 2011 |
Hawkins TB, Dantzer J, Peters B, Dinauer M, Mockaitis K, Mooney S, Cornetta K. Identifying viral integration sites using SeqMap 2.0. Bioinformatics (Oxford, England). 27: 720-2. PMID 21245052 DOI: 10.1093/Bioinformatics/Btq722 |
0.322 |
|
| 2011 |
Cornetta K, Yao J, Jasti A, Koop S, Douglas M, Hsu D, Couture LA, Hawkins T, Duffy L. Replication-competent lentivirus analysis of clinical grade vector products. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 557-66. PMID 21179010 DOI: 10.1038/Mt.2010.278 |
0.382 |
|
| 2011 |
Rosenbeck LL, Kiel PJ, Kalsekar I, Vargo C, Baute J, Sullivan CK, Wood L, Abdelqader S, Schwartz J, Srivastava S, Abonour R, Robertson MJ, Nelson RP, Cornetta K, Fausel CA, et al. Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 916-22. PMID 20932925 DOI: 10.1016/J.Bbmt.2010.09.017 |
0.301 |
|
| 2011 |
Feldman SA, Goff SL, Xu H, Black MA, Kochenderfer JN, Johnson LA, Yang JC, Wang Q, Parkhurst MR, Cross S, Morgan RA, Cornetta K, Rosenberg SA. Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a "modified" step-filtration process for clearance of packaging cells. Human Gene Therapy. 22: 107-15. PMID 20662590 DOI: 10.1089/Hum.2010.064 |
0.368 |
|
| 2011 |
Du LM, Franck HWG, Merricks EP, Nurden P, Jensen ES, Haberichter SL, Hawkins TB, Jacobi PM, Fang J, Nichols TC, Koukouritaki SB, Shi Q, Nurden AT, Montogomery RR, Cornetta K, et al. Gene Therapy Targeting Synthesis of Coagulation Factor VIII in Platelets Reduces Bleeding in Canine Hemophilia A Biology of Blood and Marrow Transplantation. 17. DOI: 10.1016/J.Bbmt.2010.12.004 |
0.306 |
|
| 2010 |
Ha SP, Klemen ND, Kinnebrew GH, Brandmaier AG, Marsh J, Hangoc G, Palmer DC, Restifo NP, Cornetta K, Broxmeyer HE, Touloukian CE. Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity. The Journal of Clinical Investigation. 120: 4273-88. PMID 21084750 DOI: 10.1172/Jci43274 |
0.376 |
|
| 2010 |
Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F, Down J, Denaro M, Brady T, Westerman K, Cavallesco R, Gillet-Legrand B, Caccavelli L, Sgarra R, Maouche-Chrétien L, ... ... Cornetta K, et al. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia. Nature. 467: 318-22. PMID 20844535 DOI: 10.1038/Nature09328 |
0.325 |
|
| 2010 |
Cornetta K. 2010 gene therapy year in review. Molecular Therapy. 18: 1417-1418. PMID 20676110 DOI: 10.1038/Mt.2010.158 |
0.374 |
|
| 2010 |
Bischof D, Cornetta K. Flexibility in cell targeting by pseudotyping lentiviral vectors. Methods in Molecular Biology (Clifton, N.J.). 614: 53-68. PMID 20225035 DOI: 10.1007/978-1-60761-533-0_3 |
0.413 |
|
| 2010 |
Du LM, Franck HWG, Merricks EP, Nurden P, Jensen ES, Haberichter SL, Hawkins TB, Jacobi PM, Fang J, Nichols TC, Koukouritaki SB, Shi Q, Montgomery RR, Cornetta K, Nurden AT, et al. De Novo Synthesis & Storage of Human Factor VIII In Platelets Reduces Bleeding In Canine Hemophilia A Blood. 116: 2198-2198. DOI: 10.1182/Blood.V116.21.2198.2198 |
0.355 |
|
| 2010 |
Tessanne K, Yao J, Cornetta K, Westhusin M, Spencer T, Long C. 434 REPLICATION COMPETENT LENTIVIRUS (RCL) ANALYSIS IN RECIPIENT ANIMALS OF TRANSGENIC EMBRYOS PRODUCED BY LENTIVIRAL TRANSFER Reproduction, Fertility and Development. 22: 374. DOI: 10.1071/Rdv22N1Ab434 |
0.441 |
|
| 2009 |
Sadat MA, Dirscherl S, Sastry L, Dantzer J, Pech N, Griffin S, Hawkins T, Zhao Y, Barese CN, Cross S, Orazi A, An C, Goebel WS, Yoder MC, Li X, ... ... Cornetta K, et al. Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation. Gene Therapy. 16: 1452-64. PMID 19657370 DOI: 10.1038/Gt.2009.96 |
0.392 |
|
| 2009 |
Cornetta K, Matheson L. The National Gene Vector Biorepository's Pharm/Tox Database. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 582-4. PMID 19337231 DOI: 10.1038/Mt.2009.55 |
0.365 |
|
| 2009 |
Sastry L, Cornetta K. Detection of replication competent retrovirus and lentivirus. Methods in Molecular Biology (Clifton, N.J.). 506: 243-63. PMID 19110631 DOI: 10.1007/978-1-59745-409-4_17 |
0.403 |
|
| 2009 |
Abonour R, Knollman H, Suvannasankha A, Yu M, Britton R, Srivastava S, Nelson RP, Schwartz JE, Robertson M, Cornetta K, Farag S. Infusion of Large Number of Circulating Myeloma Cells Does Not Influence the Survival of Patients Undergoing Autologous Stem Cell Transplantation. Blood. 114: 1224-1224. DOI: 10.1182/Blood.V114.22.1224.1224 |
0.338 |
|
| 2009 |
Nelson R, Robertson M, Schwartz J, Cornetta K, Srivastava S, Kiel P, Yu M, Wood L, Baute J, O'Bryant R, Cripe L, Abonour R, Farag S. T.133. Post-Engraftment Anti-CD25 for the Prevention of Acute Graft-versus-host disease (GVHD) after Minimally Intensive Cyclophosphamide/Fludarabine (Cy/Flu) Conditioning and Hematopoietic Cell Transplantation Clinical Immunology. 131: S91. DOI: 10.1016/J.Clim.2009.03.266 |
0.321 |
|
| 2009 |
Nelson R, Yu M, Schwartz J, Robertson M, Fausel C, Vance G, Dlouhy S, Baute J, Wood L, Cox E, Robertson K, Haut P, Farag S, Abonour R, Cornetta K, et al. T.132. Related and Unrelated Hematopoietic Cell Allotransplantation with Cyclophosphamide/ Fludarabine (Cy/Flu) Nonablative Conditioning for the Treatment of Acute Myelogenous Leukemia/Myelodysplasia Clinical Immunology. 131: S90-S91. DOI: 10.1016/J.Clim.2009.03.265 |
0.301 |
|
| 2008 |
Cornetta K, Pollok KE, Miller AD. Retroviral vectors for gene transfer. Csh Protocols. 2008: pdb.top29. PMID 21356814 DOI: 10.1101/Pdb.Top29 |
0.43 |
|
| 2008 |
Cornetta K, Pollok KE, Miller AD. Transduction of primary hematopoietic cells by retroviral vectors. Csh Protocols. 2008: pdb.prot4884. PMID 21356806 DOI: 10.1101/Pdb.Prot4884 |
0.436 |
|
| 2008 |
Cornetta K, Pollok KE, Miller AD. Transduction of cell lines by retroviral vectors. Csh Protocols. 2008: pdb.prot4883. PMID 21356805 DOI: 10.1101/Pdb.Prot4883 |
0.376 |
|
| 2008 |
Cornetta K, Pollok KE, Miller AD. Generation of stable vector-producing cells for retroviral vectors. Csh Protocols. 2008: pdb.prot4882. PMID 21356804 DOI: 10.1101/Pdb.Prot4882 |
0.431 |
|
| 2008 |
Cornetta K, Pollok KE, Miller AD. Retroviral vector production by transient transfection. Csh Protocols. 2008: pdb.prot4881. PMID 21356803 DOI: 10.1101/Pdb.Prot4881 |
0.387 |
|
| 2008 |
Jin Q, Marsh J, Cornetta K, Alkhatib G. Resistance to human immunodeficiency virus type 1 (HIV-1) generated by lentivirus vector-mediated delivery of the CCR5{Delta}32 gene despite detectable expression of the HIV-1 co-receptors. The Journal of General Virology. 89: 2611-21. PMID 18796731 DOI: 10.1099/Vir.0.2008/003624-0 |
0.38 |
|
| 2008 |
Cornetta K, Reeves L, Cross S. Production of retroviral vectors for clinical use. Methods in Molecular Biology (Clifton, N.J.). 433: 17-32. PMID 18679615 DOI: 10.1007/978-1-59745-237-3_2 |
0.343 |
|
| 2008 |
Peters B, Dirscherl S, Dantzer J, Nowacki J, Cross S, Li X, Cornetta K, Dinauer MC, Mooney SD. Automated analysis of viral integration sites in gene therapy research using the SeqMap web resource. Gene Therapy. 15: 1294-8. PMID 18580967 DOI: 10.1038/Gt.2008.99 |
0.345 |
|
| 2008 |
Ha SP, Cornetta K, Broxmeyer HE, Restifo NP, Touloukian CE. 65. CD4+ T Cell Immunity Following Gene Transfer Into Hematopoietic Stem Cells Journal of Surgical Research. 144: 204-205. DOI: 10.1016/J.Jss.2007.12.075 |
0.384 |
|
| 2007 |
Cai L, Johnstone BH, Cook TG, Liang Z, Traktuev D, Cornetta K, Ingram DA, Rosen ED, March KL. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells (Dayton, Ohio). 25: 3234-43. PMID 17901400 DOI: 10.1634/Stemcells.2007-0388 |
0.336 |
|
| 2007 |
Brannon-Peppas L, Ghosn B, Roy K, Cornetta K. Encapsulation of nucleic acids and opportunities for cancer treatment. Pharmaceutical Research. 24: 618-27. PMID 17372693 DOI: 10.1007/S11095-006-9208-X |
0.301 |
|
| 2007 |
Hsu C, Jones SA, Cohen CJ, Zheng Z, Kerstann K, Zhou J, Robbins PF, Peng PD, Shen X, Gomes TJ, Dunbar CE, Munroe DJ, Stewart C, Cornetta K, Wangsa D, et al. Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene. Blood. 109: 5168-77. PMID 17353346 DOI: 10.1182/Blood-2006-06-029173 |
0.404 |
|
| 2007 |
Tao W, Evans BG, Yao J, Cooper S, Cornetta K, Ballas CB, Hangoc G, Broxmeyer HE. Enhanced green fluorescent protein is a nearly ideal long-term expression tracer for hematopoietic stem cells, whereas DsRed-express fluorescent protein is not. Stem Cells (Dayton, Ohio). 25: 670-8. PMID 17138958 DOI: 10.1634/Stemcells.2006-0553 |
0.373 |
|
| 2006 |
Zhang S, Joseph G, Pollok K, Berthoux L, Sastry L, Luban J, Cornetta K. G2 cell cycle arrest and cyclophilin A in lentiviral gene transfer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 546-54. PMID 16901758 DOI: 10.1016/J.Ymthe.2006.05.022 |
0.668 |
|
| 2006 |
Cornetta K, Croop J, Dropcho E, Abonour R, Kieran MW, Kreissman S, Reeves L, Erickson LC, Williams DA. A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase. Cancer Gene Therapy. 13: 886-95. PMID 16645619 DOI: 10.1038/Sj.Cgt.7700963 |
0.332 |
|
| 2006 |
Hall KM, Horvath TL, Abonour R, Cornetta K, Srour EF. Decreased homing of retrovirally transduced human bone marrow CD34+ cells in the NOD/SCID mouse model. Experimental Hematology. 34: 433-42. PMID 16569590 DOI: 10.1016/J.Exphem.2005.12.014 |
0.391 |
|
| 2006 |
Sadat M, Dirscherl S, Pech N, Getty R, Cross S, Barese C, Goebel WS, Yoder MC, Mooney S, Grez M, Cornetta K, Dinauer MC. Biased Engraftment of Retrovirus-Transduced Marrow in Murine X-CGD Following Submyeloablative Conditioning. Blood. 108: 3285-3285. DOI: 10.1182/Blood.V108.11.3285.3285 |
0.387 |
|
| 2005 |
Villella AD, Yao J, Getty RR, Juliar BE, Yiannoutsos C, Hartwell JR, Cai S, Sadat MA, Cornetta K, Williams DA, Pollok KE. Real-Time PCR: an Effective Tool for Measuring Transduction Efficiency in Human Hematopoietic Progenitor Cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 483-491. PMID 28192683 DOI: 10.1016/J.Ymthe.2004.10.017 |
0.387 |
|
| 2005 |
Cornetta K, Matheson L, Ballas C. Retroviral vector production in the National Gene Vector Laboratory at Indiana University. Gene Therapy. 12: S28-35. PMID 16231053 DOI: 10.1038/Sj.Gt.3302613 |
0.432 |
|
| 2005 |
Robertson MJ, Abonour R, Hromas R, Nelson RP, Fineberg NS, Cornetta K. Augmented high-dose regimen of cyclophosphamide, carmustine, and etoposide with autologous hematopoietic stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphoma. Leukemia & Lymphoma. 46: 1477-87. PMID 16194894 DOI: 10.1080/10428190500158466 |
0.34 |
|
| 2005 |
Kahl CA, Pollok K, Haneline LS, Cornetta K. Lentiviral vectors pseudotyped with glycoproteins from Ross River and vesicular stomatitis viruses: variable transduction related to cell type and culture conditions. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 470-82. PMID 15727944 DOI: 10.1016/J.Ymthe.2004.08.032 |
0.689 |
|
| 2005 |
Carson K, Kiermer V, Borellini F, Lu X, Slepushkin V, Binder G, Dropulic B, Audit M, Barbara B, Cornetta K, Wilson C, Takefman D, Zhao Y, Carson K. Report from the Lentivirus Vector Working Group: Issues for Developing Assays and Reference Materials for Detecting Replication-Competent Lentivirus in Production Lots of Lentivirus Vectors Bioprocessing Journal. 4: 39-42. DOI: 10.12665/J42.Carson |
0.314 |
|
| 2005 |
Tao W, Graham-Evans B, Cooper S, Cornetta K, Ballas CB, Hangoc G, Broxmeyer HE. EGFP Is a Useful Long-Term Expression Tracer for Hematopoietic Stem Cells While DsRed Fluorescent Protein Is Not. Blood. 106: 3057-3057. DOI: 10.1182/Blood.V106.11.3057.3057 |
0.429 |
|
| 2005 |
Sadat M, Barese C, Pech N, Goebel WS, Yoder MC, Mooney S, Cornetta K, Grez M, Dinauer MC. Reconstitution of Neutrophil NADPH Oxidase Activity in Murine X-CGD Following Transplantation of Retrovirus-Transduced Marrow: Potential Impact of Submyeloablative Conditioning. Blood. 106: 3050-3050. DOI: 10.1182/Blood.V106.11.3050.3050 |
0.365 |
|
| 2005 |
Ballas C, Johnson T, Cornetta K. 492. Harvest Timing and Media Composition Effects on Lentiviral Vector Production Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.032 |
0.393 |
|
| 2005 |
Joseph G, Marsh J, Johnson T, Cornetta K. 94. Transgene Expression with Integration-Deficient HIV-1 Based Lentiviral Vectors Expressing Class I Integrase Mutants Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.100 |
0.424 |
|
| 2005 |
Zhang S, Pollok K, Sastry L, Berthoux L, Luban J, Cornetta K. 2. Cellular Mechanisms Involved with Lentiviral Gene Transfer Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.005 |
0.446 |
|
| 2004 |
Sastry L, Xu Y, Cooper R, Pollok K, Cornetta K. Evaluation of plasmid DNA removal from lentiviral vectors by benzonase treatment. Human Gene Therapy. 15: 221-6. PMID 14975194 DOI: 10.1089/104303404772680029 |
0.315 |
|
| 2004 |
Kahl CA, Marsh J, Fyffe J, Sanders DA, Cornetta K. Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus. Journal of Virology. 78: 1421-30. PMID 14722297 DOI: 10.1128/Jvi.78.3.1421-1430.2004 |
0.639 |
|
| 2003 |
Sastry L, Xu Y, Johnson T, Desai K, Rissing D, Marsh J, Cornetta K. Certification assays for HIV-1-based vectors: frequent passage of gag sequences without evidence of replication-competent viruses. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 830-9. PMID 14599817 DOI: 10.1016/J.Ymthe.2003.08.003 |
0.365 |
|
| 2003 |
Kohn DB, Sadelain M, Dunbar C, Bodine D, Kiem HP, Candotti F, Tisdale J, Riviére I, Blau CA, Richard RE, Sorrentino B, Nolta J, Malech H, Brenner M, Cornetta K, et al. American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 180-7. PMID 12907140 DOI: 10.1016/S1525-0016(03)00212-0 |
0.426 |
|
| 2002 |
Reeves L, Duffy L, Koop S, Fyffe J, Cornetta K. Detection of ecotropic replication-competent retroviruses: comparison of s(+)/l(-) and marker rescue assays. Human Gene Therapy. 13: 1783-90. PMID 12396630 DOI: 10.1089/104303402760293619 |
0.357 |
|
| 2002 |
Sastry L, Johnson T, Hobson MJ, Smucker B, Cornetta K. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Therapy. 9: 1155-62. PMID 12170379 DOI: 10.1038/Sj.Gt.3301731 |
0.346 |
|
| 2002 |
Mermod N, Cornetta K. Gene transfer: the ins, the outs... and the next generation Current Opinion in Biotechnology. 13: 415-417. DOI: 10.1016/S0958-1669(02)00376-2 |
0.327 |
|
| 2001 |
Chen J, Reeves L, Sanburn N, Croop J, Williams DA, Cornetta K. Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research. Virology. 282: 186-97. PMID 11259201 DOI: 10.1006/Viro.2001.0826 |
0.401 |
|
| 2001 |
Chen J, Reeves L, Cornetta K. Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors. Human Gene Therapy. 12: 61-70. PMID 11177543 DOI: 10.1089/104303401450979 |
0.437 |
|
| 2000 |
Reeves L, Cornetta K. Clinical retroviral vector production: step filtration using clinically approved filters improves titers. Gene Therapy. 7: 1993-8. PMID 11175310 DOI: 10.1038/Sj.Gt.3301328 |
0.306 |
|
| 2000 |
Reeves L, Smucker P, Cornetta K. Packaging cell line characteristics and optimizing retroviral vector titer: the National Gene Vector Laboratory experience. Human Gene Therapy. 11: 2093-103. PMID 11044911 DOI: 10.1089/104303400750001408 |
0.37 |
|
| 2000 |
Balduini A, Braun SE, Cornetta K, Lyman S, Broxmeyer HE. Comparative effects of retroviral-mediated gene transfer into primary human stromal cells of Flt3-ligand, interleukin 3 and GM-CSF on production of cord blood progenitor cells in long-term culture. Stem Cells (Dayton, Ohio). 37-49. PMID 11012147 DOI: 10.1002/Stem.5530160807 |
0.366 |
|
| 2000 |
Yanovich S, Mitsky P, Cornetta K, Maziarz RT, Rosenfeld C, Krause DS, Lotz JP, Bitran JD, Williams S, Preti R, Somlo G, Burtness B, Mills B. Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial. Bone Marrow Transplantation. 25: 1165-1174. PMID 10849529 DOI: 10.1038/Sj.Bmt.1702415 |
0.366 |
|
| 2000 |
Abonour R, Williams DA, Einhorn L, Hall KM, Chen J, Coffman J, Traycoff CM, Bank A, Kato I, Ward M, Williams SD, Hromas R, Robertson MJ, Smith FO, Woo D, ... ... Cornetta K, et al. Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nature Medicine. 6: 652-8. PMID 10835681 DOI: 10.1038/76225 |
0.44 |
|
| 2000 |
Rosenberg SA, Blaese RM, Brenner MK, Deisseroth AB, Ledley FD, Lotze MT, Wilson JM, Nabel GJ, Cornetta K, Economou JS, Freeman SM, Riddell SR, Brenner M, Oldfield E, Gansbacher B, et al. Human gene marker/therapy clinical protocols. Human Gene Therapy. 11: 919-79. PMID 10779168 DOI: 10.1089/10430340050015536 |
0.346 |
|
| 2000 |
Nakshatri H, Mendonca MS, Bhat-Nakshatri P, Patel NM, Goulet RJ, Cornetta K. The orphan receptor COUP-TFII regulates G2/M progression of breast cancer cells by modulating the expression/activity of p21(WAF1/CIP1), cyclin D1, and cdk2. Biochemical and Biophysical Research Communications. 270: 1144-53. PMID 10772965 DOI: 10.1006/Bbrc.2000.2562 |
0.316 |
|
| 1999 |
Sanburn N, Cornetta K. Rapid titer determination using quantitative real-time PCR. Gene Therapy. 6: 1340-1345. PMID 10455446 DOI: 10.1038/Sj.Gt.3300948 |
0.302 |
|
| 1999 |
Srour EF, Abonour R, Cornetta K, Traycoff CM. Ex vivo expansion of hematopoietic stem and progenitor cells: are we there yet? Journal of Hematotherapy. 8: 93-102. PMID 10349904 DOI: 10.1089/106161299320370 |
0.369 |
|
| 1998 |
Chabannon C, Cornetta K, Lotz JP, Rosenfeld C, Shlomchik M, Yanovitch S, Marolleau JP, Sledge G, Novakovitch G, Srour EF, Burtness B, Camerlo J, Gravis G, Lee-Fischer J, Faucher C, et al. High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study. British Journal of Cancer. 78: 913-21. PMID 9764583 DOI: 10.1038/Bjc.1998.601 |
0.33 |
|
| 1998 |
Traycoff CM, Halstead B, Rice S, McMahel J, Srour EF, Cornetta K. Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells. British Journal of Haematology. 102: 759-67. PMID 9722304 DOI: 10.1046/J.1365-2141.1998.00839.X |
0.327 |
|
| 1997 |
Cornetta K, Fan Y. Retroviral gene therapy in hematopoietic diseases. Journal of Clinical Apheresis. 12: 187-193. PMID 9483181 DOI: 10.1002/(Sici)1098-1101(1997)12:4<187::Aid-Jca6>3.0.Co;2-6 |
0.387 |
|
| 1997 |
Broun ER, Nichols CR, Gize G, Cornetta K, Hromas RA, Schacht B, Einhorn LH. Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer Cancer. 79: 1605-1610. PMID 9118046 DOI: 10.1002/(Sici)1097-0142(19970415)79:8<1605::Aid-Cncr25>3.0.Co;2-0 |
0.309 |
|
| 1997 |
Braun SE, Chen K, Battiwalla M, Cornetta K. Gene therapy strategies for leukemia Molecular Medicine Today. 3: 39-46. PMID 9021741 DOI: 10.1016/S1357-4310(96)10052-6 |
0.414 |
|
| 1997 |
Traycoff CM, Srour EF, Dutt P, Fan Y, Cornetta K. The 30/35 kDa chymotryptic fragment of fibronectin enhances retroviral-mediated gene transfer in purified chronic myelogenous leukemia bone marrow progenitors Leukemia. 11: 159-167. PMID 9001433 DOI: 10.1038/Sj.Leu.2400529 |
0.381 |
|
| 1996 |
Cornetta K, Srour EF, Moore A, Davidson A, Broun ER, Hromas R, Moen RC, Morgan RA, Rubin L, Anderson WF, Hoffman R, Tricot G. Retroviral gene transfer in autologous bone marrow transplantation for adult acute leukemia. Human Gene Therapy. 7: 1323-9. PMID 8818719 DOI: 10.1089/Hum.1996.7.11-1323 |
0.367 |
|
| 1996 |
Broxmeyer HE, Cooper S, Hague N, Benninger L, Sarris A, Cornetta K, Vadhan-Raj S, Hendrie P, Mantel C. Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice. Annals of Hematology. 71: 235-46. PMID 7492626 DOI: 10.1007/Bf01744373 |
0.329 |
|
| 1995 |
McCarthy LJ, Danielson CF, Cornetta K, Srour EF, Broun ER. Autologous bone marrow transplantation. Critical Reviews in Clinical Laboratory Sciences. 32: 67-119. PMID 7748468 DOI: 10.3109/10408369509084682 |
0.318 |
|
| 1994 |
Cornetta K, Moore A, Johannessohn M, Sledge GW. Clonal dominance detected in metastases but not primary tumors of retrovirally marked human breast carcinoma injected into nude mice. Clinical & Experimental Metastasis. 12: 3-12. PMID 8287617 DOI: 10.1007/Bf01784328 |
0.351 |
|
| 1994 |
Cornetta K, Moore A, Leemhuis T, Moen RC, Tricot G, Leibowitz D, Hoffman R. Retroviral mediated gene transfer in chronic myelogenous leukaemia. British Journal of Haematology. 87: 308-316. PMID 7947272 DOI: 10.1111/J.1365-2141.1994.Tb04914.X |
0.43 |
|
| 1993 |
Cornetta K, Nguyen N, Morgan RA, Muenchau DD, Hartley JW, Blaese RM, Anderson WF. Infection of human cells with murine amphotropic replication-competent retroviruses. Human Gene Therapy. 4: 579-88. PMID 8280796 DOI: 10.1089/Hum.1993.4.5-579 |
0.408 |
|
| 1992 |
Cornetta K. Safety aspects of gene therapy. British Journal of Haematology. 80: 421-426. PMID 1581226 DOI: 10.1111/J.1365-2141.1992.Tb04552.X |
0.319 |
|
| 1991 |
Culver K, Cornetta K, Morgan R, Morecki S, Aebersold P, Kasid A, Lotze M, Rosenberg SA, Anderson WF, Blaese RM. Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proceedings of the National Academy of Sciences of the United States of America. 88: 3155-9. PMID 2014235 DOI: 10.1073/Pnas.88.8.3155 |
0.353 |
|
| 1991 |
Morgan RA, Cornetta K, Anderson WF. Applications of the polymerase chain reaction in retroviral-mediated gene transfer and the analysis of gene-marked human TIL cells. Human Gene Therapy. 1: 135-49. PMID 1964093 DOI: 10.1089/HUM.1990.1.2-135 |
0.333 |
|
| 1990 |
Zwiebel JA, Freeman SM, Cornetta K, Forough R, Maciag T, Anderson WF. Recombinant gene expression in human umbilical vein endothelial cells transduced by retroviral vectors. Biochemical and Biophysical Research Communications. 170: 209-13. PMID 2164804 DOI: 10.1016/0006-291X(90)91261-P |
0.433 |
|
| 1990 |
Culver KW, Morgan RA, Osborne WRA, Lee RT, Lenschow D, Able C, Cornetta K, Anderson WF, Blaese RM. In vivo expression and survival of gene-modified T lymphocytes in rhesus monkeys Human Gene Therapy. 1: 399-410. PMID 1964096 DOI: 10.1089/Hum.1990.1.4-399 |
0.375 |
|
| 1989 |
Zwiebel JA, Freeman SM, Kantoff PW, Cornetta K, Ryan US, Anderson WF. High-level recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors. Science (New York, N.Y.). 243: 220-2. PMID 2911735 DOI: 10.1126/SCIENCE.2911735 |
0.315 |
|
| 1989 |
Cornetta K, Wieder R, Anderson WF. Gene transfer into primates and prospects for gene therapy in humans. Progress in Nucleic Acid Research and Molecular Biology. 36: 311-22. PMID 2660193 DOI: 10.1016/S0079-6603(08)60179-8 |
0.387 |
|
| Show low-probability matches. |